AI-generated summary
The authors compared intraoral and extraoral photobiomodulation in 58 patients with oral or oropharyngeal cancer receiving radiotherapy. They report no significant difference in overall oral mucositis grades or time to ulcerated mucositis between groups, while the extraoral group had less difficulty swallowing and smaller taste decline at some time points.
- Participants
- 58
- Who or what was studied
- Patients with oral or oropharyngeal squamous cell carcinoma receiving radiotherapy
- Wavelengths
- 660, 810, 980 nm
- Limits stated in the abstract
- The abstract does not describe blinding details, sample size justification or long-term follow-up, and reports multiple secondary comparisons without adjustment.
Written by an AI model from this paper’s abstract only and checked automatically against it, but it can still be wrong. It is not medical advice. Read the full paper. See the editorial policy.
Abstract
The full abstract is not shown here because it is protected by the publisher’s copyright. Read it on link.springer.com.
Record from PubMed, a service of the National Library of Medicine.
Light parameters mentioned
Found in the title and abstract by pattern. They may be incomplete, so check the paper before comparing studies.
- Wavelength
- 660 nm, 980 nm
- Energy density (fluence)
- 10 J/cm2, 6.11 J/cm2
- Power
- 100 mW, 1000 mW
How to read a trial: what to check before relying on this kind of research.
Terms in this paper: Photobiomodulation, Oral mucositis, Photobiomodulation therapy, Fluence, Laser, Trial registration. Each links to its definition in the glossary.
A summary of published research, not medical advice. One study rarely settles a question. See the disclaimer and how to read research.